Disseminated Intravascular Coagulation (DIC) Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theDisseminated Intravascular Coagulation (DIC) Market?
The rising prevalence of cancer also drives the expansion of the disseminated intravascular coagulation (DIC) market. DIC, a condition characterized by excessive clotting and bleeding, is often triggered by cancer, as tumors can produce procoagulant substances that activate the coagulation cascade. With cancer cases projected to rise significantly—the National Cancer Institute forecasts 29.9 million new cases and 15.3 million cancer-related deaths annually by 2040—there will be a greater need for DIC treatments. The increasing incidence of cancer, therefore, plays a crucial role in driving the growth of the DIC market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp
#What is the Growth Potential of the Disseminated Intravascular Coagulation (DIC) Market, and How Will It Perform by 2034?
The disseminated intravascular coagulation (DIC) market has also grown strongly, increasing from $0.46 billion in 2024 to $0.49 billion in 2025 at a CAGR of 5.3%. The historical growth factors include the rise in sepsis cases, an increase in trauma-related incidents, a growing cancer incidence, higher healthcare spending, enhanced awareness among healthcare professionals, and a rise in adoption of targeted therapies.
The disseminated intravascular coagulation (DIC) market is poised for strong growth, reaching $0.59 billion by 2029 at a CAGR of 5.0%. Growth drivers include a rising focus on targeted therapies, early disease detection efforts, greater investments in healthcare infrastructure, expanded clinical research on coagulopathy treatments, and increasing awareness of rare hematological conditions. Major trends include improved diagnostic assays, the adoption of novel anticoagulant therapies, personalized medicine approaches, AI-driven diagnostics, enhanced patient monitoring technologies, and the development of targeted treatment solutions.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21172
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theDisseminated Intravascular Coagulation (DIC) Market?
In the disseminated intravascular coagulation (DIC) market, companies are advancing coagulation diagnostic technologies, such as next-generation blood clotting tests, to improve accuracy and speed in diagnosing DIC. For example, in June 2022, LumiraDx Limited, a UK-based healthcare company, expanded its cardiovascular testing portfolio, gaining CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These tests enhance the LumiraDx Platform, supporting clinicians in diagnosing heart failure and ruling out venous thromboembolism, improving early detection and management of DIC and other thrombotic conditions.
Who Are the Key Market Players Influencing the Growth of the Corn and Disseminated Intravascular Coagulation (DIC) Industry?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Disseminated Intravascular Coagulation (DIC) Market and Drive Its Revenue Growth?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented –
1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21172&type=smp
Which Regions Are Emerging as Leaders in the Disseminated Intravascular Coagulation (DIC) Market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Disseminated Intravascular Coagulation (DIC) Market 2025, By The Business Research Company:
Severe Acute Respiratory-Syndrome Treatment Global Market Report 2025
Myelodysplastic Syndrome (MDS) Drugs Global Market Report 2025
Hospital-Acquired Infection Control Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
